Skip to main content
. 2021 Jun 6;10(2):1171–1188. doi: 10.1007/s40122-021-00274-9

Table 2.

Outcomes of Italian Questionnaire for BTcP diagnosis, χ2analysis, and Spearman rank correlation analysis

IQ-BTP Total n (%) χ2c Spearman rank correlation (ρ value)e
Item IQ-BTP subset
Sample 753 (100.0)
1—Pain/pain therapy present Constantd Constantd
Yes 753 (100.0)
No 0 (0.0)
2—Strong opioid therapy 412.017 0.237 Mild
Yes 655 (87.0)
No 98 (13.0)
3—BP intensity (NRS ≤  4) 226.519 0.330 Mild
Yes 583 (77.4)
No 170 (22.6)
4—Pain from flairs (NRS ≥ 6) 2.689 0.649 Moderate
Yes 354 (47.0)
No 399 (53.0)
5—Flairs are not related to therapy schedule? 156.240 0.420 Moderate
Yes 512 (68.0)
No 241 (32.0)
Potential-BTPa 205 (27.2)
 6—Flair frequency (24 h) 534.558 0.989 Strong
 < 5 = 1 133 (17.7)
 ≥ 5 = 2 72 (9.6)
 7—Flair duration 555.355 0.992 Strong
 ≤ 30–60 min = 1 162 (21.5)
 > 60 min = 2 43 (5.7)
 BTP likelihoodb 939.074 0.987 Strong
Low (items 6 and 7 = 4) 18 (2.4)
Intermediate (items 6 and 7 = 3) 79 (10.5)
High (items 6 and 7 = 2) 108 (14.3)
Total 205 (27.2)
 8—Different sites for flair and BP? 540.462 0.266 Mild
Yes 66 (8.8)
No 139 (18.5)
 9—Flairs are predictable? 540.215 0.989 Strong
Yes 53 (7.0)
No 152 (20.2)
 10—Flair cause known? 531.179 0.988 Strong
Yes 80 (10.6)
No 125 (16.6)
 11—Dysesthesias/paresthesias present? 527.243 0.988 Strong
Yes 99 (13.1)
No 106 (14.1)

BP Background pain, BTcp breakthrough pain in cancer, BTP breakthrough pain, χ2 Chi-square, IQ-BTP Italian Questionnaire for BTcP, NRS numeric rating scale

aCases with ‘yes’ answers throughout items 1–5 (yielding potential-BTcP)

bSum of items 6 and 7 outcomes (= 4, 3, or 2), yielding low, intermediate, and high BTP likelihood, respectively

cχ2-analysis, association of IQ-BTcP items and potential-BTcP; P-value = 0.000, respectively

dAll cases were ‘Yes’ thus constant

eSpearman-rank correlation between IQ-BTcP items and the IQ-BTP outcomes; results are expressed as ρ absolute values